Flagship Ventures, founded in 2000, is a venture capital firm operating from its offices at Kendall Square in Cambridge, MA. As of 2010 it manages over $600 million in early-stage funds. With a portfolio of over 40 companies, the firm's strategy is to aim to balance its investments across three business sectors: Therapeutics, Life Science Tools and Diagnostics, and BioEnergy/Cleantech.
Flagship Ventures' Investment Size
Flagship Ventures' initial investment may range between $250 thousand and $5 million with a typical investment of $2.5 million to $4 million. It may invest up to $15-20 million during the life of a...
More >>
Flagship Ventures, founded in 2000, is a venture capital firm operating from its offices at Kendall Square in Cambridge, MA. As of 2010 it manages over $600 million in early-stage funds. With a portfolio of over 40 companies, the firm's strategy is to aim to balance its investments across three business sectors: Therapeutics, Life Science Tools and Diagnostics, and BioEnergy/Cleantech.
Flagship Ventures' Investment Size
Flagship Ventures' initial investment may range between $250 thousand and $5 million with a typical investment of $2.5 million to $4 million. It may invest up to $15-20 million during the life of a venture and typically form a syndicate that includes other leading venture firms. Flagship's principals have been involved as founders or investors in many ventures including: Adnexus Therapeutics, Alere Medical, Aspect Medical, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Cytyc, DataSage, Exact Sciences, Helicos Biosciences, Hypnion, IDEXX, Morphotek, PerSeptive Biosystems and TripAdvisor.
<< Less
|